Skip to main content
OpenTrials

Clinical trial condition

Stage IIIC2 Uterine Corpus Cancer

Explore clinical trials studying Stage IIIC2 Uterine Corpus Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Stage IIIC2 Uterine Corpus Cancer trial results

Completed

Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer

NCT00729586

Conditions
Endometrial Carcinoma, Endometrial Neoplasms, Female Urogenital Diseases, +17 more
Locations
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of California San Diego San Diego, California, United States
  • Colorado Gynecologic Oncology Group Aurora, Colorado, United States
View all 108 locations
View Trial Details

Related conditions